Shi Minglan, Li Xiqing, Feng Jiao, Jia Shulin, Xiao Xing, Chen Chunmei, Fransisca Cindy, Xi Liyan, Zhang Junmin
Department of Dermatology and Venerology, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Department of Dermatology, Guangdong Province Hospital of Chinese Medicine, Guangzhou, China.
J Clin Lab Anal. 2018 Feb;32(2). doi: 10.1002/jcla.22257. Epub 2017 May 22.
Chromoblastomycosis (CBM) is a chronic fungal disease. In China, the principle etiologic agent was a group of dematiaceous fungi, including Fonsecaea monophora, Fonsecaea nubica, and Cladophialophora carrionii. Although the Fonsecaea species have similar morphology, their pathogenicity is quite different. This study aims to establish a new solution for early identification of Fonsecaea species because of their distinctive potential infection risk.
Five reference strains and 35 clinical isolates from patients with CBM, preserved in our laboratory, were used in this study. The universal primer ITS1 and ITS2 were chosen to amplify the highly conserved regions of rDNA. High-resolution melting (HRM) analysis was performed using the LIGHTCYCLER 96 System. All the amplicons were verified by direct sequencing and the sequence were aligned with those in GenBank by BLAST analysis.
We successfully differentiated the five strains according to their different Tm values and curve shapes. The 35 clinical isolates from patients were identified as 24 strains for F. monophora and 11 strains for F. nubica, which is consistent with the DNA sequencing results.
It is the first time to use HRM analysis for identification of Fonsecaea species. Since the CBM etiologic agent in South China is mainly F. monophora and F. nubica, this strategy is sufficient to be applied in the clinical examination with high accuracy, speed, and throughput.
着色芽生菌病(CBM)是一种慢性真菌病。在中国,主要病原体是一组暗色真菌,包括单孢瓶霉、暗瓶霉和卡氏枝孢瓶霉。虽然瓶霉属物种形态相似,但其致病性却大不相同。由于其独特的潜在感染风险,本研究旨在建立一种早期鉴定瓶霉属物种的新方法。
本研究使用了保存在我们实验室的5株参考菌株和35例CBM患者的临床分离株。选择通用引物ITS1和ITS2扩增rDNA的高度保守区域。使用LIGHTCYCLER 96系统进行高分辨率熔解(HRM)分析。所有扩增子均通过直接测序进行验证,并通过BLAST分析将序列与GenBank中的序列进行比对。
我们根据不同的熔解温度(Tm)值和曲线形状成功区分了这5株菌株。35例患者的临床分离株被鉴定为24株单孢瓶霉和11株暗瓶霉,这与DNA测序结果一致。
首次使用HRM分析鉴定瓶霉属物种。由于中国南方CBM的病原体主要是单孢瓶霉和暗瓶霉,该策略足以在临床检测中以高精度、高速度和高通量应用。